Asia-Pacific Cardiac Monitoring Market - Growth, Trends, and Forecast (2020 - 2025)

The market is segmented By Device Type, End-User, and Geography

Market Snapshot

Study Period:


Base Year:



5.6 %

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Cardiac monitoring devices are used to monitor and diagnose various abnormalities or disorders of the heart. The cardiac monitoring market is driven by rising burden of cardiovascular diseases, a growing ageing population who are very susceptible to coronary heart diseases, technological developments in cardiac monitoring devices that minimise the chances of infection, and improved efficiency of devices. Smoking is one of the major underlying causes of lung cancer and cardiac diseases. According to World Health Organisation (WHO), smoking causes around 1 million cardiovascular deaths in Asia-Pacific region each year. More than 1 in 5 cardiovascular diseases, such as heart attack and stroke, result from smoking. The Heart Foundation states that CVD is a major cause of death in Australia, with 43,477 deaths attributed to CVD in 2017. The rate of diagnosis of cardiovascular diseases is increasing over time due to rising burden of cardiac diseases and the need to control mortality rate by early diagnosis, and treatment for CVD with the help of cardiac monitoring devices. The other factors, such as technological advancements and the demand for home-based, point of care and remote monitoring cardiac systems are also anticipated to drive the market in the forecast period.

Scope of the report

Continuous cardiac monitoring is an important tool in the clinical assessment of patients with a variety of conditions. It allows the detection of changes in heart rate and rhythm and is essential in the detection of life-threatening arrhythmia's.

Report scope can be customized per your requirements. Click here.

Key Market Trends

ECG Monitor Segment is Expected to Show Better Growth in the Forecast Years

Based on Device type, the market is segmented into ECG Monitor, Event Recorder, Implantable Cardiac Loop Recorder, Pacemaker, Defibrillator, CRT Devices, Smart Wearable and others. The ECG devices can be used for the continuous monitoring of patients suffering from CVD and for the detection of problems when they are usually easier to treat, while avoiding life-threatening and expensive emergency admissions. The development of commercially advanced devices, with enabled Bluetooth sensor technology and mobile app technology is expected to drive the popularity of ECG Monitors. In 2018, Qardio, Inc., received the approval from Australia’s Therapeutic Goods Administration (TGA) for QardioCore, its revolutionary ECG monitor. Furthermore, technological advancements and product innovations taking place in the development of ECG devices are likely to propel the market growth.

To understand key trends, Download Sample Report

Competitive Landscape

The major players into the Asia-Pacific cardiac monitoring market are Abbott Laboratories, Biotronik, Boston Scientific Corporation, GE Healthcare, Hill-Rom Holdings, Inc., Medtronic PLC, MicroPort Scientific, Schiller AG.

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Cardiovascular Diseases

      2. 4.2.2 Demand for Home-based, Point of Care and Remote Patients Monitoring Cardiac Systems

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Infection Due to Implantable Monitoring Devices

      2. 4.3.2 Lack of Skilled Personnel

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Device Type

      1. 5.1.1 ECG Monitor

      2. 5.1.2 Event Recorder

      3. 5.1.3 Implantable Cardiac Loop Recorder

      4. 5.1.4 Pacemaker

      5. 5.1.5 Defibrillator

      6. 5.1.6 Cardiac Resynchronization Therapy (CRT) Devices

      7. 5.1.7 Smart Wearable

      8. 5.1.8 Other Device Types

    2. 5.2 End User

      1. 5.2.1 Hospitals and Clinics

      2. 5.2.2 Home Care Settings

      3. 5.2.3 Ambulatory Surgical Centers

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Biotronik

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 GE Healthcare

      5. 6.1.5 Hill-Rom Holdings, Inc.

      6. 6.1.6 Medtronic PLC

      7. 6.1.7 MicroPort Scientific

      8. 6.1.8 Schiller AG

  7. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Related Reports